Penumbra (FRA:0P8) Beginning Cash Position: €209 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:0P8 Penumbra Inc FRA:0P8
88 GF Score
Price €278.00
GF Value €287.01
! 1 Warning Sign
View Full Analysis

What is Penumbra Beginning Cash Position?

Penumbra FRA:0P8 +0.43% 88 Beginning Cash Position is €209 Mil as of Jun. 2026. GuruFocus rates FRA:0P8 with a GF Score™ of 88/100 and a GF Value™ of €287.01. The stock has 1 warning sign investors should review.

Penumbra's Beginning Cash Position for the quarter that ended in Jun. 2026 was €209 Mil.

Penumbra's quarterly Beginning Cash Position declined from Dec. 2025 (€274 Mil) to Mar. 2026 (€162 Mil) but then increased from Mar. 2026 (€162 Mil) to Jun. 2026 (€209 Mil).

Penumbra's annual Beginning Cash Position increased from Dec. 2023 (€64 Mil) to Dec. 2024 (€160 Mil) and increased from Dec. 2024 (€160 Mil) to Dec. 2025 (€277 Mil).

Penumbra Beginning Cash Position Related Terms

Penumbra Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Penumbra's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Penumbra Beginning Cash Position Chart

Penumbra Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 61.66 56.05 64.06 159.95 277.04

Penumbra Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 326.04 359.35 274.16 161.67 209.44
FRA:0P8
88GF Score
Penumbra Inc FRA:0P8
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Penumbra Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of €209 Mil mean?
Penumbra (FRA:0P8) has a Beginning Cash Position of €209 Mil as of Jun. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Penumbra and its competitors.
Is Penumbra's Beginning Cash Position too high?
Penumbra's current Beginning Cash Position is €209 Mil. Overall, Penumbra has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Penumbra's Beginning Cash Position compare to PODD and GMED?
Penumbra's Beginning Cash Position of €209 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Devices & Instruments company?
A good Beginning Cash Position depends on the Medical Devices & Instruments industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Penumbra and its competitors. Penumbra's current Beginning Cash Position is €209 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Penumbra stock overvalued right now?
Penumbra (FRA:0P8) has a current Beginning Cash Position of €209 Mil. The stock's GF Value™ is €287.01, compared to a current price of €278.00 — trading 3.1% below its estimated fair value. The current Beginning Cash Position is €209 Mil. Penumbra's overall GF Score™ is 88/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Penumbra (FRA:0P8), the current Beginning Cash Position is €209 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Penumbra (FRA:0P8) Overvalued in 2026?

Based on GuruFocus' analysis, Penumbra stock appears to be undervalued. The current stock price of €278.00 is trading 3.1% below its estimated GF Value™ of €287.01.

Key valuation signals for FRA:0P8:

  • Beginning Cash Position: €209 Mil
  • GF Value™: €287.01 vs. price of €278.00 (3.1% below fair value)
  • GF Score™: 88/100 with 1 warning sign

No single metric tells the full story. See the FRA:0P8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Penumbra Business Description

Other Exchanges PEN:USA
Address 1310 Harbor Bay Parkway, One Penumbra Place, Alameda, CA, USA, 94502
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.
88GF Score

Get the complete analysis for FRA:0P8

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€278.00
Price
€287.01
GF Value